Statins in the prevention of contrast-induced nephropathy

Current Treatment Options in Cardiovascular Medicine
Anthony C ChyouRajesh V Swaminathan

Abstract

Coronary angiography and percutaneous coronary interventions are common procedures that utilize iodinated contrast medium to visualize the coronary arterial tree and treat stable and unstable ischemic heart syndromes. Exposure to contrast agents can cause acute and persistent worsening of renal function leading to increased morbidity and mortality. Certain patient characteristics such as age, presence of diabetes, congestive heart failure, chronic kidney disease, hemodynamic instability on presentation, and type and volume of contrast used can increase the risk of developing contrast-induced nephropathy (CIN) and its subsequent complications. Despite the lack of a universal definition, CIN is typically defined as an increase in serum creatinine ≥0.5 mg/dL or 25 % above baseline 48 to 72 h after contrast exposure. Previous research has shown the benefits of adequate intravenous hydration with iso-osmolar crystalloids and the importance of limiting the amount of low-osmolar and iso-osmolar contrast used to prevent the development of CIN. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have anti-inflammatory and anti-apoptotic properties with few side effects, making it an attractive therapeutic option for pre...Continue Reading

References

Jun 15, 2004·The American Journal of Cardiology·Beth A BartholomewWilliam W O'Neill
Sep 2, 2004·Journal of the American Society of Nephrology : JASN·Rajiv Agarwal
Sep 24, 2004·Current Medical Research and Opinion·William McClellanMarc Leiserowitz
Jan 22, 2005·Fundamental & Clinical Pharmacology·Michael Schachter
Feb 12, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Pontus B Persson, Andreas Patzak
Jun 22, 2006·JAMA : the Journal of the American Medical Association·Neesh PannuUNKNOWN Alberta Kidney Disease Network
Aug 11, 2006·Kidney & Blood Pressure Research·Dalibor LecianRadko Komers
Sep 5, 2006·The American Journal of Cardiology·James TumlinUNKNOWN CIN Consensus Working Panel
Sep 5, 2006·The American Journal of Cardiology·Fulvio StaculUNKNOWN CIN Consensus Working Panel
Apr 12, 2008·Journal of the American College of Cardiology·Peter A McCullough
Jan 1, 2007·Journal of Medical Economics·Sujha SubramanianTeresa Zyczynski
Sep 30, 2010·Nature Reviews. Nephrology·Andrew D CalvinAxel Pflueger
Jun 4, 2011·International Journal of Cardiology·Reji PappyMazen S Abu-Fadel
Jul 26, 2011·Seminars in Nephrology·Steven D Weisbord, Paul M Palevsky
Sep 29, 2011·The Canadian Journal of Cardiology·Bu-Chun ZhangYa-Wei Xu
Jan 24, 2012·European Heart Journal·Erdmann SeeligerPontus B Persson
Mar 24, 2012·Clinical Medicine Insights. Cardiology·Ahai LuvaiJulian H Barth
Nov 14, 2012·Circulation·Cristina QuintavalleGerolama Condorelli
Dec 15, 2012·The British Journal of Radiology·C S KwokY K Loke
Apr 2, 2014·Postgraduate Medicine·Peter P Toth
Apr 8, 2014·Journal of Thrombosis and Thrombolysis·Lucia BarbieriGiuseppe De Luca
May 24, 2014·The American Journal of Medicine·Sumeet GandhiMichael E Farkouh
Jul 18, 2014·Journal of Cardiovascular Medicine·Sang-Ho JoHyeon-Cheol Gwon
Jul 19, 2014·Coronary Artery Disease·Hongzhi XieYong Zeng

❮ Previous
Next ❯

Citations

Jul 25, 2015·Expert Review of Cardiovascular Therapy·Vasilios G AthyrosAsterios Karagiannis
Apr 3, 2018·Journal of Translational Internal Medicine·An VerdoodtHerbert D Spapen
Nov 25, 2020·Angiology·Muhammad Asif KabeerSheikh Tawqeer Rashid

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.